Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 17, Issue 3 (May 2015) 17, 503–507; doi: 10.4103/1008-682X.142129

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml-1 and 10.1–20.0 ng ml-1: a multicenter study

Yu‑Rong Lin1,2,*, Xing‑Hua Wei1,*, Matthew Uhlman3, Xuan‑Ting Lin1, Si‑Feng Wu1, Peng‑Fei Diao1, Hai‑Qing Xie1, Ke‑Ji Xie1, Ping Tang1

1Department of Urology, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou 510180, China; 2Department of Urology, Jieyang People’s Hospital, Jieyang 522000, China; 3Department of Urology, University of Iowa, Iowa City, IA 52242, USA.

Correspondence: Dr. P Tang (pingtang09@yahoo.com)

2014-11-28

Abstract

Chinese men should have a higher prostate‑specific antigen (PSA) “gray zone” than the traditional value of 2.5–10.0 ng ml−1 since the incidence of prostate cancer (PCa) in Chinese men is relative low. We hypothesized that PSA density (PSAD) could improve the rate of PCa detection in Chinese men with a PSA higher than the traditional PSA “gray zone.” A total of 461 men with a PSA between 2.5 and 20.0 ng ml−1, who had undergone prostatic biopsy at two Chinese centers were included in the analysis. The men were then further divided into groups with a PSA between 2.5–10.0 ng ml−1 and 10.1–20.0 ng ml−1. Receiver operating characteristic (ROC) curve was used to evaluate the efficacy of PSA and PSAD for the diagnosis of PCa. In men with a PSA of 2.5–10.0 ng ml−1 or 10.1–20.0 ng ml−1, the areas under the ROC curve were higher for PSAD than for PSA. This was consistent across both centers and the cohort overall. When the entire cohort was considered, the optimal PSAD cut‑off for predicting PCa in men with a PSA of 2.5–10.0 ng ml−1 was 0.15 ng ml−1 ml−1, with a sensitivity of 64.4% and specificity of 64.6%. The optimal cut‑off for PSAD in men with a PSA of 10.1–20.0 ng ml−1 was 0.33 ng ml−1 ml−1, with a sensitivity of 60.3% and specificity of 82.7%. PSAD can improve the effectiveness for PCa detection in Chinese men with a PSA of 2.5–10.0 ng ml−1 (traditional Western PSA “gray zone”) and 10.1–20.0 ng ml−1 (Chinese PSA “gray zone”).

Keywords: area under the receiver operating characteristic curve; prostate cancer; prostate‑specific antigen; prostate‑specific antigen density

Full Text | PDF | 中文摘要 |

 
Browse:  1705
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.